newsfilter
← Latest News
Business Wire·

Forma Therapeutics Reviews 2020 Highlights and Outlines Key 2021 Milestones

WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, today provided a review of corporate highlights from 2020 and outlined anticipated key clinical program milestones for 2021.